Results from pre-clinical studies demonstrate immunomodulatory activity of QEL-005 across multiple immune cell lineages involved in complex autoimmune inflammation, including B cells, T cells and ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
The integration of artificial intelligence (AI) into drug discovery is revolutionizing pharmaceutical research by providing sophisticated tools for understanding and predicting complex biological ...
MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...
Given the critical importance of endocytosis detection in ADC research and development, ACROBiosystems has designed an ...
Functional vision improvements are reported, with optimal pupil size considerations for varying light conditions being ...
It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...
Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best small cap stocks with the highest upside. Barclays initiated ...
Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
The company is dropping its social anxiety disorder program but will still test the molecule in post-traumatic stress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback